Head and Neck Screenings
Dever Dental joined forces with Forward Science, the manufacturer of OralID™, and became a provider of the ID For Life™ Program to promote early detection and public awareness of oral cancer in the office. Dr. Martha Dever offers enhanced oral cancer screenings during scheduled appointments to new and current patients.
Oral Cancer is not a rare disease and unfortunately it is on the rise. This year, approximately 45,780 will be diagnosed with oral cancer in the United States alone. Due to late stage discovery, one American dies every hour from oral cancer.
Dr. Dever uses an oral cancer screening device, OralID, in efforts to discover oral cancers in their earliest stages. Currently, 63% of oral cancers are found in late stages (stage III, IV), resulting in a 5-year survival rate of less than 50%. Finding these abnormalities in much earlier stages can increase the 5-year survival rate up to 80-90%.
Those interested in receiving an oral cancer screening or learning more about our advanced technology implemented at Dever Dental, contact our office at (513) 777-6444 and ask about our OralID screenings,
About Forward Science LLC
Forward Science is a biotech company based in Houston, TX. OralID, Forward Science’s flagship product, is an award winning oral cancer screening device that allows clinicians to Shine Light. Save Lives.™ by identifying abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer.
With the launch of the ID For Life™ Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life™ Program includes the following in an effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options for dry mouth (SalivaMAX).
Dever Dental is a part of the ID For Life™ Program and offers all of the above services to their patients. For more information on OralID please visit http://www.forwardscience.com/oralid.